Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000386932

Medchemexpress LLC Cep-28122 (mesylate salt) | 2070009-30-0 | 99.9% | 635.17 | 1 ML
SDP

Catalog No. 5000386932
Encompass_Preferred

CEP-28122 mesylate salt, a diaminopyrimidine derivative, is a potent, selective, and orally active ALK inhibitor with an IC50 value of 1.9 nM. It exhibits antitumor activity in experimental models of ALK-positive human cancers and possesses good pharmacodynamic and pharmacokinetic activity. This product can be utilized for the study of ALK-positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroblastoma cells.

  • Potent, selective, and orally active ALK inhibitor with an IC50 value of 1.9 nM.
  • Exhibits antitumor activity in experimental models of ALK-positive human cancers.
  • Possesses good pharmacodynamic and pharmacokinetic activity.
  • Can be used for the study of ALK-positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroblastoma cells.

Catalog No. 50-003-86932 Supplier Medchemexpress LLC Supplier No. HY18030A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

CEP-28122 mesylate salt, a diaminopyrimidine derivative, is a potent, selective, and orally active ALK inhibitor with an IC50 value of 1.9 nM. It exhibits antitumor activity in experimental models of ALK-positive human cancers and possesses good pharmacodynamic and pharmacokinetic activity. This product can be utilized for the study of ALK-positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroblastoma cells.

  • Potent, selective, and orally active ALK inhibitor with an IC50 value of 1.9 nM.
  • Exhibits antitumor activity in experimental models of ALK-positive human cancers.
  • Possesses good pharmacodynamic and pharmacokinetic activity.
  • Can be used for the study of ALK-positive anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), and neuroblastoma cells.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.